Atlas Trials

Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4

Clinical trial NCT03578640 · COMPLETED

Trial details

NCT number
NCT03578640
Sponsor
King Fahad Medical City
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2018-07-01
Primary completion
2020-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.